Home » Topics » Medical technology

Medical technology
RSS

Amgen's GDNF Misses In Phase II Parkinson's Trial

June 29, 2004

Amgen Inc.'s therapy for Parkinson's disease failed to meet its primary endpoint in a Phase II study. (BioWorld Today)

Other News To Note

June 29, 2004

LSBC, University Of Louisville Join Up To Develop HPV Drugs

June 29, 2004

Appointments And Advancements

June 29, 2004

Virogenomics New Spin-Off Artielle: $11M For MS Work

June 29, 2004

Stock Winners and Losers For The Week

June 28, 2004

BioWorld Stock Report For Public Biotechnology Companies

June 28, 2004

Medarex Paying $4.7M To Acquire Ability Biomedical

June 28, 2004

By Aaron Lorenzo

Biotechnology Company Deals With Other Biotechnology Companies: Collaborations, Agreements, Equity Participation, April 29 - June 23, 2004

June 28, 2004

Tarceva Blockbuster'May Falter In Second Line, But There's Hope

June 28, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...